The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Cardiac Allograft Vasculopathy: A Review
Abstract
Abstract Cardiac allograft vasculopathy (CAV) remains a troublesome long-term complication of heart transplantation. It is manifested by a unique and unusually accelerated form of coronary disease affecting both intramural and epicardial coronary arteries and veins. CAV is characterized by vascular injury induced by a variety of noxious stimuli, including the immune system response to the allograft, ischemia-reperfusion injury, viral infection, immunosuppressive drugs, and classic risk factors such as hyperlipidemia, insulin resistance, and hypertension. The obstructive vascular lesions are thought to progress through repetitive endothelial injury followed by repair response. The role of major histocompatibility complex donor-recipient differences in the pathogenesis of CAV has not yet been completely elucidated. Intracoronary ultrasound studies reveal a dual morphology with donor-transmitted or de novo focal, noncircumferential plaques in proximal segments and/or a diffuse, concentric pattern observed in distal segments. A lack of correlation between microvascular and epicardial vessel disease suggests discordant manifestations and progression of CAV. Apoptosis and loss of functional vascular remodeling have to be considered as important mediators of clinically relevant CAV. Strategies for blocking T-cell costimulation and expression of adhesion molecules may help prevent chronic rejection in clinical transplantation. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and antiproliferative drugs may slow progression of CAV by various effects. Methods to augment endogenous nitric oxide bioavailability as well as newer immunosuppressive regimens may be protective. Balloon angioplasty has a limited role in the treatment of focal lesions. Experiences with coronary stenting, coronary artery bypass grafting, and transmyocardial laser revascularization are limited. Retransplantation has a worse outcome than initial transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Effect of pravastatin on outcomes after cardiac transplantation
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331003 · Cited by 1,301
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
Grattan, M. T. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420240075030 · Cited by 968
Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., & Henry, P. D. (1990) · Nature · doi:10.1038/344160a0 · Cited by 858
von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 762
Apoptosis in Human Atherosclerosis and Restenosis
Isner, J. M., Kearney, M., Bortman, S., & Passeri, J. (1995) · Circulation · doi:10.1161/01.cir.91.11.2703 · Cited by 672
Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells
Marx, S. O., Jayaraman, T., Go, L. O., & Marks, A. R. (1995) · Circulation Research · doi:10.1161/01.res.76.3.412 · Cited by 599
St Goar, F. G., Pinto, F. J., Alderman, E. L., Valantine, H. A., Schroeder, J. S., Gao, S. Z., Stinson, E. B., & Popp, R. L. (1992) · Circulation · doi:10.1161/01.cir.85.3.979 · Cited by 475
Gene therapy inhibiting neointimal vascular lesion
Leyen, V. D. (1995) · Medical Entomology and Zoology · Cited by 386
Pollman, M. J., Yamada, T., Horiuchi, M., & Gibbons, G. H. (1996) · Circulation Research · doi:10.1161/01.res.79.4.748 · Cited by 341
The spectrum of coronary artery pathologic findings in human cardiac allografts.
Johnson, D. E., Gao, S. Z., Schroeder, J. S., et al. (1989) · PubMed · Cited by 280
Notarbartolo, A., Davı̀, G., Averna, M., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. P. L., & Patrono, C. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.247 · Cited by 259
Responses of coronary arteries of cardiac transplant patients to acetylcholine.
Fish, R. D., Nabel, E. G., Selwyn, A. P., Ludmer, P. L., Mudge, G. H., Kirshenbaum, J. M., Schoen, F. J., Alexander, R. W., & Ganz, P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113297 · Cited by 229
Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant
Smart, F. W., Ballantyne, C. M., Cocanougher, B., Farmer, J. A., Sekela, M. E., Noon, G. P., & Young, J. B. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90553-w · Cited by 204
Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients
Halle, A. A., DiSciascio, G., Massin, E. K., Wilson, R. F., Johnson, M. R., Sullivan, H. J., Bourge, R. C., Kleiman, N. S., Miller, L. W., Aversano, T. R., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00124-i · Cited by 197
Szabolcs, M., Michler, R. E., Yang, X., Aji, W., Roy, D., Athan, E., Sciacca, R. R., Minanov, O. P., & Cannon, P. J. (1996) · Circulation · doi:10.1161/01.cir.94.7.1665 · Cited by 196
Land, W., Messmer, K., & Events, E. (1996) · Transplantation Reviews · doi:10.1016/s0955-470x(96)80016-4 · Cited by 193
Retransplantation for severe accelerated coronary artery disease in heart transplant recipients
Gao, S. Z., Schroeder, J. S., Hunt, S., & Stinson, E. B. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90885-5 · Cited by 189
Rickenbacher, P. R., Pinto, F. J., Lewis, N. P., Hunt, S. A., Alderman, E. L., Schroeder, J. S., Stinson, E. B., Brown, B. W., & Valantine, H. A. (1995) · Circulation · doi:10.1161/01.cir.92.12.3445 · Cited by 180
Russell, M. E., Hancock, W. W., Akalin, E., Wallace, A. F., Glysing-Jensen, T., Willett, T. A., & Sayegh, M. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118483 · Cited by 174
Pham, S. M., Kormos, R. L., Hattler, B. G. J., Kawai, A., Tsamandas, A. C., Demetris, A. J., Murali, S., Fricker, F. J., Chang, H. C., Jain, A. B., et al. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70336-7 · Cited by 158
Dong, C., Wilson, J. E., Winters, G. L., & McManus, B. M. (1996) · PubMed · Cited by 150
Seiler, C. A., Hess, O. M., Buechi, M., Suter, T., & Krayenbuehl, H. P. (1993) · Circulation · doi:10.1161/01.cir.88.5.2139 · Cited by 142
Russell, M. E., Wallace, A. F., Wyner, L. R., Newell, J. B., & Karnovsky, M. J. (1995) · Circulation · doi:10.1161/01.cir.92.3.457 · Cited by 139
Drexler, H., Fischell, T. A., Pinto, F. J., Chenzbraun, A., Botas, J., Cooke, J. P., & Alderman, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.4.1615 · Cited by 128
Endothelial nitric oxide and cardiovascular disease
Wennmalm, A. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01081.x · Cited by 122
Mehra, M. R., Ventura, H. O., Smart, F. W., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80432-9 · Cited by 112
Role of mevalonic acid in the regulation of natural killer cell cytotoxicity
Cutts, J., Scallen, T. J., Watson, J. A., & Bankhurst, A. D. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390314 · Cited by 99
Escobar, A., Ventura, H. O., Stapleton, D. D., Mehra, M. R., Ramee, S. R., Collins, T. J., Jain, S. P., Smart, F. W., & White, C. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90856-7 · Cited by 98
Loss of the coronary microvascular response to acetylcholine in cardiac transplant patients.
Treasure, C. B., Vita, J. A., Ganz, P., et al. (1992) · Circulation · doi:10.1161/01.cir.86.4.1156 · Cited by 94
Requirement for mevalonate in cycling cells: Quantitative and temporal aspects
Doyle, J. W., & Kandutsch, A. A. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041370116 · Cited by 68
Reversal of lovastatin‐mediated inhibition of natural killer cell cytotoxicity by interleukin 2
Cutts, J., & Bankhurst, A. D. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450208 · Cited by 67
Ardehali, A. A., Laks, H., Drinkwater, D. C., Ziv, E., & Drake, T. A. (1995) · Circulation · doi:10.1161/01.cir.92.3.450 · Cited by 67
Metabolic risk factors for atherosclerosis in heart transplant recipients
Kemna, M. S., Valantine, H. A., Hunt, S. A., Schroeder, J. S., Chen, Y. I., & Reaven, G. M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90011-6 · Cited by 64
Chemical Weathering in Central Iceland: An Analog of Pre-Silurian Weathering
Cawley, J. L., Burruss, R. C., & Holland, H. D. (1969) · Science · doi:10.1126/science.165.3891.391 · Cited by 55
Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts.
Gulizia, J. M., Kandolf, R., Kendall, T. J., Thieszen, S. L., Wilson, J. E., Radio, S. J., Costanzo, M. R., Winters, G. L., Miller, L. L., & McManus, B. M. (1995) · Europe PMC (PubMed Central) · Cited by 46
Cited by
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Cells in focus: endothelial cell
Sumpio, B. E., Timothy Riley, J., & Dardik, A. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00075-4 · Cited by 531
Sartore, S., Chiavegato, A., Faggin, E., Franch, R., Puato, M., Ausoni, S., & Pauletto, P. (2001) · Circulation Research · doi:10.1161/hh2401.100844 · Cited by 515
Cardiovascular Toxicities of Immunosuppressive Agents
Miller, L. W. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20902.x · Cited by 467
Allograft Vasculopathy Versus Atherosclerosis
Rahmani, M., Cruz, R. P., Granville, D. J., & McManus, B. M. (2006) · Circulation Research · doi:10.1161/01.res.0000246086.93555.f3 · Cited by 347
Metadata
- Authors
- Weis, M., & von Scheidt, W.
- Venue
- Circulation
- Published
- 1997-09-16
- Volume
- 96
- Issue
- 6
- Pages
- 2069-2077
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2035881418
- Cited by
- 433
- References
- 36
- FWCI
- 31.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.